Center for Clinical Epidemiology and Population Health (CCEPH) researchers presented findings from recent studies on influenza, respiratory syncytial virus (RSV), and measles, mumps, rubella (MMR) vaccine at ID Week in San Diego, Oct 4-8. Huong McLean, PhD, gave an oral presentation on prior season influenza vaccination and risk of vaccine failure with the live attenuated influenza vaccine (FluMist) and inactivated influenza vaccine in children. Jennifer King, MPH, presented a poster on RSV epidemiology and clinical outcomes in older adults seen as outpatients in the Marshfield Clinic Health System. Emma Seagle, MPH, former SRIP intern, presented her thesis work on patterns of persistence and decline of measles, mumps, and rubella antibody following receipt of the second dose of MMR vaccine. IDWeek is an international infectious disease meeting sponsored by the Infectious Disease Society of America (IDSA) and three other professional organizations.
Links to the presented abstracts and associated Marshfield Clinic authors are below.
RSV Epidemiology and Clinical Outcomes in Adults ≥60 Years of Age Seeking Outpatient Care for Respiratory Illness
Authors: Jennifer King, Burney Kieke, Joanna Pluta, Ali Al-Hilli, Edward Belongia
Measles, Mumps, and Rubella Antibody: Patterns of Persistence and Rate of Decline Following the Second Dose of the MMR Vaccine
Authors: Emma Seagle, Tenisha Hill, Edward Belongia, Huong McLean